Abstract
Connections between the multi-ome and epigenetic age acceleration (EAA), and especially whether these are influenced by genetic or environmental factors, remain underexplored. We therefore quantified associations between the multi-ome comprising four layers – the proteome, metabolome, external exposome, and lifestyle – with six different EAA estimates. Two twin cohorts were used in a discovery-replication scheme, comprising respectively young (N=642; mean age= 22.3) and older (N=354; mean age=62.3) twins. Within-pair twin designs were used to assess genetic and environmental effects on associations. We identified 40 multi-omic factors, of which 28 were proteins, associated with EAA in the young twins while adjusting for sex, smoking, and body mass index. Within-pair analyses showed that genetic confounding heterogeneously affected these associations, with six multi-omic factors remaining significantly associated with EAA independent of genetic effects. Replication in older twins showed that some of these associations persist across adult generations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MO and JK acknowledge support from the Sigrid Juselius Foundation. GD and ZW have been supported by the doctoral programs of the University of Helsinki.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In FinnTwin12, ethical approval for all data collection waves was obtained from the ethical committee of the Helsinki and Uusimaa University Hospital District and the Institutional Review Board of Indiana University. All data collection and sampling protocols were performed in compliance with the ethical guidelines. Parents provided consent for the twins aged 12 and 14 years old, while twins aged 17 and 22 years old provided written consent themselves for sample collection. The EH-Epi study protocol was approved by the Institutional Ethics Board of the Hospital District of Helsinki and Uusimaa, Finland (ID 154/13/03/00/11) and the Institutional Review Board of Augusta University. Omics datasets were obtained from within the FTC (Kaprio et al., 2019) for up to 444 twins, and all applicable written and informed consent was obtained in relation to the data generated or used for analysis.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes